Top Cited Articles

We are delighted to announce the 2017 impact factor for Thorax is 9.655 (Journal Citation Reports (c) Clarivate Analytics), and is placed 5th within the Respiratory Systems category. This is a testament to the vision of Editors-in-Chief Gisli Jenkins, Nicholas Hart and Alan Smyth and their team to serve the international research community by publishing the very best papers across respiratory medicine.

To mark this achievement we list below the 30 articles that have received the most citations over the past year and made them free to read:


Chest electrical impedance tomography examination, data analysis, terminology, clinical use and recommendations: consensus statement of the TRanslational EIT developmeNt stuDy group
Frerichs I, Amato MBP, van Kaam AH, et al

Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval
Yousaf-Khan U, van der Aalst C, de Jong PA, et al

Nintedanib in patients with idiopathic pulmonary fibrosis and preserved lung volume
Kolb M, Richeldi L, Behr J, et al

Physiotherapy, and speech and language therapy intervention for patients with refractory chronic cough: a multicentre randomised control trial
Chamberlain Mitchell SAF, Garrod R, Clark L, et al

Randomised, double-blind, placebo-controlled trial with azithromycin selects for anti-inflammatory microbial metabolites in the emphysematous lung
Segal LN, Clemente JC, Wu BG, et al

Home-based rehabilitation for COPD using minimal resources: a randomised, controlled equivalence trial
Holland AE, Mahal A, Hill CJ, et al

Preparation for a first-in-man lentivirus trial in patients with cystic fibrosis
Alton EWFW, Beekman JM, Boyd AC, et al

Different dyspnoea perception in COPD patients with frequent and infrequent exacerbations
Scioscia G, Blanco I, Arismendi E, et al

The use of pretest probability increases the value of high-resolution CT in diagnosing usual interstitial pneumonia
Brownell R, Moua T, Henry TS, et al

Bronchiectasis and the risk of cardiovascular disease: a population-based study
Navaratnam V, Millett ERC, Hurst JR, et al


Blood eosinophils and inhaled corticosteroid/long-acting beta-2 agonist efficacy in COPD
Pavord ID, Lettis S, Locantore N, et al

Interobserver agreement for the ATS/ERS/JRS/ALAT criteria for a UIP pattern on CT
Walsh SLF, Calandriello L, Sverzellati N on behalf of The UIP Observer Consort, et al

UK Lung Cancer RCT Pilot Screening Trial: baseline findings from the screening arm provide evidence for the potential implementation of lung cancer screening
Field JK, Duffy SW, Baldwin DR, et al

US Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus recommendations for the management of non-tuberculous mycobacteria in individuals with cystic fibrosis
Floto RA, Olivier KN, Saiman L, et al

Effect of continued treatment with pirfenidone following clinically meaningful declines in forced vital capacity: analysis of data from three phase 3 trials in patients with idiopathic pulmonary fibrosis
Nathan SD, Albera C, Bradford WZ, et al

International Committee on Mental Health in Cystic Fibrosis: Cystic Fibrosis Foundation and European Cystic Fibrosis Society consensus statements for screening and treating depression and anxiety
Quittner AL, Abbott J, Georgiopoulos AM the International Committee on Mental Health, et al

Comorbidity in severe asthma requiring systemic corticosteroid therapy: cross-sectional data from the Optimum Patient Care Research Database and the British Thoracic Difficult Asthma Registry
Sweeney J, Patterson CC, Menzies-Gow A on behalf of the British Thoracic Society Difficult Asthma Network, et al

BTS/ICS guideline for the ventilatory management of acute hypercapnic respiratory failure in adults
Davidson AC, Banham S, Elliott M, et al

Physical frailty and pulmonary rehabilitation in COPD: a prospective cohort study
Maddocks M, Kon SSC, Canavan JL, et al

beta-Blockers are associated with a reduction in COPD exacerbations
Bhatt SP, Wells JM, Kinney GL For the COPDGene Investigators, et al


Lebrikizumab in moderate-to-severe asthma: pooled data from two randomised placebo-controlled studies
Hanania NA, Noonan M, Corren J, et al

External validation of blood eosinophils, FENO and serum periostin as surrogates for sputum eosinophils in asthma
Wagener AH, de Nijs SB, Lutter R, et al

British Thoracic Society guidelines for the investigation and management of pulmonary nodules
Callister MEJ, Baldwin DR, Akram AR, et al

The clinical spectrum of pulmonary aspergillosis
Kosmidis C, Denning DW

Asthma-COPD overlap 2015: now we are six
Gibson PG, McDonald VM

Accelerated ageing of the lung in COPD: new concepts
Mercado N, Ito K, Barnes PJ

Heterogeneous gene expression signatures correspond to distinct lung pathologies and biomarkers of disease severity in idiopathic pulmonary fibrosis
DePianto DJ, Chandriani S, Abbas AR, et al

Which individuals are at increased risk of pneumococcal disease and why? Impact of COPD, asthma, smoking, diabetes, and/or chronic heart disease on community-acquired pneumonia and invasive pneumococcal disease
Torres A, Blasi F, Dartois N, et al

The cost of treating severe refractory asthma in the UK: an economic analysis from the British Thoracic Society Difficult Asthma Registry
O’Neill S, Sweeney J, Patterson CC, et al

Characteristics of COPD in never-smokers and ever-smokers in the general population: results from the CanCOLD study
Tan WC, Sin DD, Bourbeau J, et al